Provided by Tiger Fintech (Singapore) Pte. Ltd.

ArriVent BioPharma

25.22
+0.33001.33%
Post-market: 25.220.00000.00%19:59 EDT
Volume:441.50K
Turnover:11.11M
Market Cap:862.84M
PE:-6.66
High:25.58
Open:25.10
Low:24.55
Close:24.89
Loading ...
Jun 20, 2025

Major Issues Report

Form 8-K - Current report
May 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2025

Major Issues Report

Form 8-K - Current report
Apr 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 03, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Mar 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 22, 2025

Major Issues Report

Form 8-K - Current report
Dec 04, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 11, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Jul 09, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jul 09, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]